These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 18453527

  • 1. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [Abstract] [Full Text] [Related]

  • 2. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [Abstract] [Full Text] [Related]

  • 3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G, Costello M, Pitout JD.
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [Abstract] [Full Text] [Related]

  • 4. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY, Choi HJ, Choi JY, Song M, Song Y, Kim SW, Chang HH, Jung SI, Kim YS, Ki HK, Son JS, Kwon KT, Heo ST, Yeom JS, Shin SY, Chung DR, Peck KR, Song JH, Ko KS.
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [Abstract] [Full Text] [Related]

  • 5. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martínez-Ruiz R, Pérez-Vázquez M, Alcaraz M, García-Cobos S, Campos J.
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [Abstract] [Full Text] [Related]

  • 6. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S.
    J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.
    Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A, Norwegian ESBL Study Group.
    APMIS; 2009 Jul; 117(7):526-36. PubMed ID: 19594493
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK, Arslan H, Serefhanoğlu K, Colakoğlu S, Erdoğan H, Timurkaynak F, Senger SS.
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [Abstract] [Full Text] [Related]

  • 10. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH.
    J Clin Microbiol; 2008 Dec; 46(12):3900-5. PubMed ID: 18842941
    [Abstract] [Full Text] [Related]

  • 11. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, André C, Scientific Committee of ONERBA.
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y.
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN).
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [Abstract] [Full Text] [Related]

  • 17. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A.
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.